157 related articles for article (PubMed ID: 20536976)
1. Is there an association between neurocognitive performance and medication adherence in first episode psychosis?
Lepage M; Bodnar M; Joober R; Malla A
Early Interv Psychiatry; 2010 May; 4(2):189-95. PubMed ID: 20536976
[TBL] [Abstract][Full Text] [Related]
2. Social cognitive markers of short-term clinical outcome in first-episode psychosis.
Montreuil T; Bodnar M; Bertrand MC; Malla AK; Joober R; Lepage M
Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):105-14. PubMed ID: 20643633
[TBL] [Abstract][Full Text] [Related]
3. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. Impact of symptom resolution on medication adherence in first episode psychosis.
Steger KA; Cassidy C; Rabinovitch M; Joober R; Malla A
Psychiatry Res; 2012 Mar; 196(1):45-51. PubMed ID: 22377571
[TBL] [Abstract][Full Text] [Related]
6. [Duration of untreated psychosis in first-episode schizophrenia: clinical and cognitive correlates].
Galińska B; Szulc A; Czernikiewicz A
Psychiatr Pol; 2005; 39(5):859-68. PubMed ID: 16358587
[TBL] [Abstract][Full Text] [Related]
7. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
Miller BJ
J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
[TBL] [Abstract][Full Text] [Related]
8. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment predictors of cognitive deficits in early psychosis.
González-Blanch C; Crespo-Facorro B; Alvarez-Jiménez M; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Barquero JL
Psychol Med; 2008 May; 38(5):737-46. PubMed ID: 17922942
[TBL] [Abstract][Full Text] [Related]
10. Predicting medication adherence and employment status following kidney transplant: The relative utility of traditional and everyday cognitive approaches.
Gelb SR; Shapiro RJ; Thornton WJ
Neuropsychology; 2010 Jul; 24(4):514-26. PubMed ID: 20604625
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
Jabben N; Arts B; van Os J; Krabbendam L
J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive development in first episode psychosis 5 years follow-up: associations between illness severity and cognitive course.
Barder HE; Sundet K; Rund BR; Evensen J; Haahr U; Ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld H; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Simonsen E; Vaglum P; McGlashan T; Friis S
Schizophr Res; 2013 Sep; 149(1-3):63-9. PubMed ID: 23810121
[TBL] [Abstract][Full Text] [Related]
13. Case manager- and patient-rated alliance as a predictor of medication adherence in first-episode psychosis.
Montreuil TC; Cassidy CM; Rabinovitch M; Pawliuk N; Schmitz N; Joober R; Malla AK
J Clin Psychopharmacol; 2012 Aug; 32(4):465-9. PubMed ID: 22722507
[TBL] [Abstract][Full Text] [Related]
14. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis.
Carlsson R; Nyman H; Ganse G; Cullberg J
Acta Psychiatr Scand; 2006 Feb; 113(2):102-11. PubMed ID: 16423161
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic medications: linking receptor antagonism to neuropsychological functioning in first episode psychosis.
Baitz HA; Thornton AE; Procyshyn RM; Smith GN; MacEwan GW; Kopala LC; Barr AM; Lang DJ; Honer WG
J Int Neuropsychol Soc; 2012 Jul; 18(4):717-27. PubMed ID: 22472219
[TBL] [Abstract][Full Text] [Related]
17. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
18. Cognitive decline following psychosis onset: data from the PACE clinic.
Wood SJ; Brewer WJ; Koutsouradis P; Phillips LJ; Francey SM; Proffitt TM; Yung AR; Jackson HJ; McGorry PD; Pantelis C
Br J Psychiatry Suppl; 2007 Dec; 51():s52-7. PubMed ID: 18055938
[TBL] [Abstract][Full Text] [Related]
19. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
20. Predictors of medication adherence in patients with schizophrenia and bipolar disorder.
Jónsdóttir H; Opjordsmoen S; Birkenaes AB; Simonsen C; Engh JA; Ringen PA; Vaskinn A; Friis S; Sundet K; Andreassen OA
Acta Psychiatr Scand; 2013 Jan; 127(1):23-33. PubMed ID: 22900964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
